Fate Therapeutics
(FATE)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 12-2019 | 12-2018 | 12-2017 | 12-2016 | 12-2015 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 99,814 | 190,514 | 88,952 | 88,609 | 64,809 |
| Marketable Securities | 121,613 | 10,493 | 11,997 | 3,503 | N/A |
| Receivables | N/A | 500 | N/A | N/A | N/A |
| TOTAL | $227,089 | $205,196 | $102,596 | $93,323 | $65,652 |
| Non-Current Assets | |||||
| PPE Net | 11,419 | 5,125 | 2,550 | 1,579 | 2,160 |
| Investments And Advances | 39,440 | 0 | 0 | 0 | 0 |
| Other Non-Current Assets | 24,326 | 2,711 | 146 | 146 | 146 |
| TOTAL | $75,185 | $7,836 | $2,696 | $1,725 | $2,306 |
| Total Assets | $302,274 | $213,032 | $105,292 | $95,048 | $67,958 |
| Liabilities | |||||
| Current Liabilities | |||||
| Short Term Debt | N/A | 2,438 | N/A | 8,187 | 7,550 |
| Accounts payable and accrued liabilities | 5,822 | 4,205 | 1,678 | 934 | 996 |
| Accrued Expenses | 14,697 | 10,926 | 7,254 | 3,957 | 2,439 |
| Other current liabilities | 2,808 | 2,106 | 12 | 4 | 55 |
| TOTAL | $27,806 | $27,263 | $11,049 | $15,187 | $13,441 |
| Non-Current Liabilities | |||||
| Long Term Debt | N/A | 12,446 | 14,808 | 2,501 | 10,688 |
| Deferred Revenues | 2,787 | 7,588 | 2,105 | 2,105 | 2,401 |
| Other Non-Current Liabilities | 25,937 | 5,354 | 1,522 | 1,377 | 857 |
| TOTAL | $29,712 | $25,300 | $17,054 | $6,707 | $16,479 |
| Total Liabilities | $57,518 | $52,563 | $28,103 | $21,894 | $29,920 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 75,931 | 65,000 | 52,769 | 41,387 | 28,862 |
| Common Shares | 76 | 65 | 53 | 41 | 29 |
| Retained earnings | -383,545 | -285,396 | -218,798 | -175,846 | -142,384 |
| Other shareholders' equity | 25 | 1 | 0 | 2 | 0 |
| TOTAL | $244,756 | $160,469 | $77,189 | $73,154 | $38,038 |
| Total Liabilities And Equity | $302,274 | $213,032 | $105,292 | $95,048 | $67,958 |